Cargando…
Dendritic Cell-Based Immunotherapy for Solid Tumors()()
As a treatment for solid tumors, dendritic cell (DC)-based immunotherapy has not been as effective as expected. Here, we review the reasons underlying the limitations of DC-based immunotherapy for solid tumors and ask what can be done to improve immune cell-based cancer therapies. Several reports sh...
Autores principales: | Jung, Nam-Chul, Lee, Jun-Ho, Chung, Kwang-Hoe, Kwak, Yi Sub, Lim, Dae-Seog |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154348/ https://www.ncbi.nlm.nih.gov/pubmed/29627706 http://dx.doi.org/10.1016/j.tranon.2018.03.007 |
Ejemplares similares
-
Tolerogenic dendritic cell-based immunotherapy
por: Chang, Kiyuk, et al.
Publicado: (2017) -
The Effect of the Tumor Microenvironment and Tumor-Derived Metabolites on Dendritic Cell Function
por: Lee, Jun-Ho, et al.
Publicado: (2020) -
Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
por: Dolcetti, Riccardo, et al.
Publicado: (2020) -
Functional Ambivalence of Dendritic Cells: Tolerogenicity and Immunogenicity
por: Nam, Ji-Hee, et al.
Publicado: (2021) -
Recent Advances in CAR-Based Solid Tumor Immunotherapy
por: Shin, Min Hwa, et al.
Publicado: (2023)